December 18, 2017 / 12:17 PM / 9 months ago

BRIEF-Ionis' License Agreement For Huntington's Disease Drug Receives Hart-Scott-Rodino Clearance

Dec 18 (Reuters) - Ionis Pharmaceuticals Inc:

* IONIS' LICENSE AGREEMENT FOR HUNTINGTON'S DISEASE DRUG, IONIS-HTT RX, RECEIVES HART-SCOTT-RODINO CLEARANCE

* IONIS PHARMACEUTICALS INC - IONIS HAS EARNED A $45 MILLION LICENSE FEE FROM ROCHE

* IONIS PHARMACEUTICALS INC - ROCHE IS NOW RESPONSIBLE FOR ALL IONIS-HTT(RX) DEVELOPMENT, REGULATORY AND COMMERCIALIZATION ACTIVITIES AND COSTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below